ERBB2 and breast cancer: However, analysis of ANXA3 expression in breast cancers of different molecular subtypes revealed significantly (P = 0.026) higher levels of ANXA3 in triple-negative breast cancer compared to those in the three other groups (Luminal A, Luminal B, and HER-2 positive types).